Original Research
Accepted on 30 Apr 2026
Serum Metabolomic Signatures Predict Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Treated with Pembrolizumab plus Platinum-based Chemotherapy
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 30 Apr 2026
in Cancer Immunity and Immunotherapy
Review
Accepted on 30 Apr 2026
in Inflammation
Original Research
Accepted on 30 Apr 2026
in Primary Immunodeficiencies
Original Research
Accepted on 30 Apr 2026
in Viral Immunology
Perspective
Accepted on 30 Apr 2026
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Review
Accepted on 30 Apr 2026
in Inflammation
Original Research
Accepted on 30 Apr 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 30 Apr 2026
in Elite Sports and Performance Enhancement
Review
Accepted on 30 Apr 2026
in Crop and Product Physiology
Original Research
Accepted on 30 Apr 2026
in Genetics of Common and Rare Diseases
Mini Review
Accepted on 30 Apr 2026
in Elections and Representation
Original Research
Accepted on 30 Apr 2026
in Agricultural and Food Economics
Review
Accepted on 30 Apr 2026
in Non-Neuronal Cells
Systematic Review
Accepted on 30 Apr 2026
in Oncology Reviews: Reviews
Methods
Accepted on 30 Apr 2026
in Health Communications and Behavior Change
Original Research
Accepted on 30 Apr 2026
in Cellular Neurophysiology